Circulating microRNA-23b as a New Biomarker for Rheumatoid Arthritis
You will be notified via email when you are eligible to purchase
At present, active pharmaceutical ingredients (API) available for many of these peptides exist only as research-grade, which cannot lawfully be used in compounded drug products dispensed to patients
Raza A, Galili N, Callander N, Ochoa L, Piro L, Emanuel P et al
The aim of this study was to determine the efficacy and safety of intramuscular methylcobalamin in the treatment of chronic nonspecific low back pain
For a broader understanding of peptide safety across different compounds, our guide on safe peptides for women and peptides for women over 40 address gender-specific safety considerations